The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Inflammatory mechanisms linking obesity and metabolic disease
Open accessAbstract
There are currently over 1.9 billion people who are obese or overweight, leading to a rise in related health complications, including insulin resistance, type 2 diabetes, cardiovascular disease, liver disease, cancer, and neurodegeneration. The finding that obesity and metabolic disorder are accompanied by chronic low-grade inflammation has fundamentally changed our view of the underlying causes and progression of obesity and metabolic syndrome. We now know that an inflammatory program is activated early in adipose expansion and during chronic obesity, permanently skewing the immune system to a proinflammatory phenotype, and we are beginning to delineate the reciprocal influence of obesity and inflammation. Reviews in this series examine the activation of the innate and adaptive immune system in obesity; inflammation within diabetic islets, brain, liver, gut, and muscle; the role of inflammation in fibrosis and angiogenesis; the factors that contribute to the initiation of inflammation; and therapeutic approaches to modulate inflammation in the context of obesity and metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This suggests that self-reported insomnia appears to result in a shift towards Th2 immunity”
From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [484]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
The global obesity pandemic: shaped by global drivers and local environments
Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., & Gortmaker, S. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60813-1 · Cited by 4,888
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Self-citationMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Self-citation
Cited by
Sorted by citations
Items 301–400 of 1,002
Basolo, A., Poma, A. M., Bonuccelli, D., Proietti, A., Macerola, E., Ugolini, C., Torregrossa, L., Giannini, R., Vignali, P., Basolo, F., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01742-5 · Cited by 57
Zhao, X.-Y., Li, S., DelProposto, J. L., Liu, T., Mi, L., Porsche, C. E., Peng, X., Lumeng, C. N.-K., & Lin, J. D. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.005 · Cited by 55
Shin, C. H., & Choi, D. (2019) · Cells · doi:10.3390/cells8020178 · Cited by 56
Proprotein convertases: Key players in inflammation-related malignancies and metastasis
Siegfried, G., Descarpentrie, J., Évrard, S., & Khatib, A. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.027 · Cited by 57
“[1] and rheumatoid arthritis is intimately linked to lymphoma development [11].”
BackgroundVisceral Adipose Tissue Accumulation and Residual Cardiovascular Risk
Jemtel, T. H. L., Samson, R., Milligan, G. P., Jaiswal, A., & Oparil, S. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0880-0 · Cited by 56
Guido, G., Ausenda, G., Iascone, V., & Chisari, E. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.2014557 · Cited by 62
Effects of glycine on metabolic syndrome components: a review
Imenshahidi, M., & Hossenzadeh, H. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01720-3 · Cited by 54
Livshits, G., & Kalinkovich, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101852 · Cited by 56
Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth
Bacha, F. F., Hannon, T. S., Tosur, M., Pike, J. M., Butler, A. M., Tommerdahl, K. L., & Zeitler, P. S. (2024) · Diabetes Care · doi:10.2337/dci24-0029 · Cited by 62
He, L., Su, Z., & Wang, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1393575 · Cited by 70
“Normally, NF-κ B and JNK, as well as the inflammatory factor interleukin-6 (IL-6), mediate insulin resistance (54, 55).”
Mamun, M. A. A., Rakib, A., Mandal, M., & Singh, U. P. (2025) · Cells · doi:10.3390/cells14060463 · Cited by 64
Hoevenaars, F. P. M., Esser, D., Schutte, S., Priebe, M. G., Vonk, R. J., van den Brink, W. J., van der Kamp, J. W., Stroeve, J. H. M., Afman, L. A., & Wopereis, S. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz177 · Cited by 54
“Protection against an increased inflammatory status caused by WGW consumption could provide a beneficial health effect in persons at risk for the development of lifestyle-related disorders, as inflammation has been postulated as the main cause for metabolic disease (42, 43).”
BackgroundYu, L., Lǐ, Y., Du, C., Zhao, W., Zhang, H., Yang, Y., Sun, A., Song, X., & Feng, Z. (2019) · Mediators of Inflammation · doi:10.1155/2019/5271295 · Cited by 58
“The development of obesity is closely associated with serious metabolic disorders, such as insulin resistance, type 2 diabetes mellitus (T2DM), hepatic steatosis, and cardiovascular disease, which cause significant morbidity and mortality worldwide [1].”
BackgroundInflammation: major denominator of obesity, Type 2 diabetes and Alzheimer’s disease-like pathology?
Kacířová, M., Zmeškalová, A., Kořínková, L., Železná, B., Kuneš, J., & Maletı́nská, L. (2020) · Clinical Science · doi:10.1042/cs20191313 · Cited by 56
Obesity is Associated with Poor Covid-19 Outcomes: A Systematic Review and Meta-Analysis
Hoong, C. W. S., Hussain, I., Aravamudan, V. M., Phyu, E. E., Lin, J. H. X., & Koh, H. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1326-2125 · Cited by 53
“Increased adiposity has been proposed to exacerbate a proinflammatory phenotype by increasing proinflammatory adipokines and reducing anti-inflammatory adipokines [52], resulting in a chronic inflammatory process that involves tonic activation of the innate immune system [53].”
BackgroundMillar, S., Navarro, P., Harrington, J. M., Shivappa, N., Hébert, J. R., Perry, I. J., & Phillips, C. M. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02892-1 · Cited by 55
“Although the production of inflammatory mediators is an essential mechanism by which leukocytes confer immune protection in response to tissue injury, excessive weight gain leads to adipose tissue remodelling with the release of adipose-derived pro-inflammatory cytokines and free fatty acids into circulation, leading…”
BackgroundMetabolic syndrome — a new definition and management guidelines
Dobrowolski, P., Prejbisz, A., Kuryłowicz, A., Baska, A., Burchardt, P., Chlebus, K., Dzida, G. J., Jankowski, P., Jaroszewicz, J., Jaworski, P., et al. (2022) · Arterial Hypertension · doi:10.5603/ah.a2022.0012 · Cited by 66
Boscaini, S., Skuse, P., Nilaweera, K. N., Cryan, J. F., & Cotter, P. D. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.12.009 · Cited by 59
Netrin-1 Alters Adipose Tissue Macrophage Fate and Function in Obesity
Sharma, M., Schlegel, M., Brown, E. J., Sansbury, B. E., Weinstock, A., Afonso, M. S., Corr, E. M., Solingen, C. V., Shanley, L. C., Peled, D., et al. (2019) · Immunometabolism · doi:10.20900/immunometab20190010 · Cited by 55
“Obesity triggers a poorly understood systemic immune response characterized by the recruitment of macrophages and other immune cells to key metabolic tissues [1].”
BackgroundInfluentialNatural Aporphine Alkaloids with Potential to Impact Metabolic Syndrome
Wang, F., Zhu, N., Zhou, F., & Lin, D.-X. (2021) · Molecules · doi:10.3390/molecules26206117 · Cited by 52
“Metabolic syndrome is defined as a set of risk factors for various diseases such as cardiovascular disease and type 2 diabetes, causing a significant source of morbidity and mortality [1,2].”
BackgroundHDAC11, an emerging therapeutic target for metabolic disorders
Chen, H., Xie, C., Chen, Q., & Zhuang, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.989305 · Cited by 55
GPSM1 impairs metabolic homeostasis by controlling a pro-inflammatory pathway in macrophages
Yan, J. Y., Zhang, Y., Yu, H., Zong, Y., Wang, D., Zheng, J., Jin, L., Yu, X., Liu, C., Zhang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34998-9 · Cited by 56
Immunometabolism and metainflammation in obesity
Romantsova, T. I., & Sych, Y. P. (2019) · Obesity and metabolism · doi:10.14341/omet12218 · Cited by 63
A comprehensive metabolic profiling of the metabolically healthy obesity phenotype
Telle‐Hansen, V. H., Christensen, J. J., Formo, G. A., Holven, K. B., & Ulven, S. M. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01273-z · Cited by 54
“Obesity and cardio-metabolic disorders associate with chronic low-grade inflammation [39].”
Huang, J., Li, W., Liao, W., Hao, Q., Tang, D., Wang, D., Wang, Y., & Ge, G. (2020) · Food & Function · doi:10.1039/d0fo02152k · Cited by 51
Müller, A., Zimmermann-Klemd, A. M., Lederer, A., Hannibal, L., Kowarschik, S., Huber, R., & Storz, M. A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18199998 · Cited by 51
Lim, J.-J., Jung, A.-H., Suh, H. J., Choi, H., & Kim, H. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111066 · Cited by 53
New approaches targeting brown adipose tissue transplantation as a therapy in obesity
Soler‐Vázquez, M. C., Mera, P., Zagmutt, S., Serra, D., & Herrero, L. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.022 · Cited by 55
Impact of obesity on the increasing incidence of type 1 diabetes
Buzzetti, R., Zampetti, S., & Pozzilli, P. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14022 · Cited by 53
“Obesity favours insulin resistance, causing stress on β cells and rendering them more vulnerable to an autoimmune attack.(42) The Wilkin's hypothesis received definitive confirmation by a recent study testing whether raised BMI accelerates islet autoimmunity before T1D diagnosis.”
High‐fat diet‐induced adipose tissue expansion occurs prior to insulin resistance in C57BL/6J mice
He, M., Wang, J., Wang, Y., Sui, J., Zhang, M., Ding, X., Yang, Z., Chen, Z., Ren, X., & Shi, B. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.06.003 · Cited by 55
“Accumulating evidence and our study suggested that metabolic low-grade inflammation in eWAT might play an essential role in the development of obesity-relatedmetabolic dysfunction,(10,25,26) resulting in an increase in total serum cholesterol and LDL-C concentrations, and is associated with dyslipidemia.(27) The influ…”
BackgroundPavlov, V. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107794 · Cited by 50
Zhang, C., Liu, S., & Yang, M. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.808526 · Cited by 57
“Chronic Inflammation Low-grade chronic inflammation displays a key role in obesity and metabolic disorder (27).”
BackgroundVahdat, M., Hosseini, S. A., Mohseni, G. K., Heshmati, J., & Rahimlou, M. (2020) · Nutrition Journal · doi:10.1186/s12937-020-00548-6 · Cited by 50
An update of prenylated phenolics: Food sources, chemistry and health benefits
Chang, S. K., Jiang, Y., & Yang, B. J. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.12.022 · Cited by 51
Chen, L., Yang, Y., Sun, S., Xie, Y., Pan, C., Li, M., Li, C., Liu, Y., Xu, Z., Liu, W., et al. (2022) · FEBS Journal · doi:10.1111/febs.16470 · Cited by 52
Aberrant inflammatory profile in acute but not recovered anorexia nervosa
Nilsson, I. A. K., Millischer, V., Göteson, A., Hübel, C., Thornton, L. M., Bulik, C. M., Schalling, M., & Landén, M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.024 · Cited by 52
Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Wang, T., Zhou, D., & Hong, Z. (2025) · MedComm · doi:10.1002/mco2.70030 · Cited by 46
Lin, J., Sun‐Waterhouse, D., & Cui, C. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1934813 · Cited by 49
Adipose Tissue-Endothelial Cell Interactions in Obesity-Induced Endothelial Dysfunction
Li, M., Qian, M., Kyler, K., & Xu, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.681581 · Cited by 50
“9 billion people are predicted to be obese or overweight, worldwide (1).”
BackgroundObesity-associated microglial inflammatory activation paradoxically improves glucose tolerance
Douglass, J. D., Ness, K. M., Valdearcos, M., Wyse‐Jackson, A. C., Dorfman, M. D., Frey, J. M., Fasnacht, R. D., Santiago, O. D., Niraula, A., Banerjee, J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.008 · Cited by 52
Gao, W., Wang, W., Zhang, J., Deng, P., Hu, J., Yang, J. M., & Deng, Z. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00443-y · Cited by 52
Lewandowska, M., Więckowska, B., Sajdak, S., & Lubiński, J. (2020) · Nutrients · doi:10.3390/nu12092681 · Cited by 49
Obesity and Dyslipidemia Synergistically Exacerbate Psoriatic Skin Inflammation
Ikeda, K., Morizane, S., Akagi, T., Hiramatsu, S., Tachibana, K., Yahagi, A., Iseki, M., Kaneto, H., Wada, J., Ishihara, K., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084312 · Cited by 52
“Obesity is a chronic inflammatory condition accompanied by metabolic dysregulation [5].”
BackgroundLi, N., Shi, H., Guo, Q., Gan, Y., Zhang, Y., Jia, J., Zhang, L., & Zhou, Y. (2022) · Nutrients · doi:10.3390/nu14183730 · Cited by 52
“Chronic inflammation plays a causal role in the development of IR [2,3], which is associated with a variety of tissues, including adipose tissue, skeletal muscle, liver, pancreas islet, and even the brain [4,5].”
BackgroundOh, D.-H., & Lee, J.-K. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20053991 · Cited by 56
“Obesity refers to the excessive accumulation of fat in the human body due to excessive caloric intake, irregular lifestyle, and lack of physical activity and is a known cause of various adult diseases, such as diabetes, high blood pressure, hyperlipidemia, and cardiovascular disease [2].”
BackgroundLiu, Y., Chen, Y., Zhang, J., Liu, Y., Zhang, Y., & Su, Z. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.782391 · Cited by 48
“The inflammatory processes in adipose tissue contribute to several obesity-associated health problems, including insulin resistance, type 2 diabetes, cardiovascular disease, fatty liver, airway disease, musculoskeletal disorders, and a variety of cancers (4).”
BackgroundHypothalamic Dysfunction in Obesity and Metabolic Disorders
Carmo‐Silva, S., & Cavadas, C. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-63260-5_4 · Cited by 53
Khosravi-Largani, M., Nojomi, M., Aghili, R., Otaghvar, H. A., Tanha, K., Seyedi, S. H. S., & Mottaghi, A. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3550-z · Cited by 48
Immune Regulation of Metabolic Homeostasis by Helminths and Their Molecules
van der Zande, H. J. P., Zawistowska‐Deniziak, A., & Guigas, B. (2019) · Trends in Parasitology · doi:10.1016/j.pt.2019.07.014 · Cited by 49
Sudhakaran, M., & Doseff, A. I. (2020) · Molecules · doi:10.3390/molecules25112477 · Cited by 49
“Hence, a disrupted macrophage– adipocyte crosstalk results in a harmful paracrine loop that exacerbates inflammation-mediated responses in the obese adipose tissue (Figure 2) [98-100].”
BackgroundEfferocytic Defects in Early Atherosclerosis Are Driven by GATA2 Overexpression in Macrophages
Yin, C., Vrieze, A. M., Rosoga, M., Akingbasote, J. A., Pawlak, E. N., Jacob, R. A., Hu, J. K., Sharma, N., Dikeakos, J. D., Barra, L., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594136 · Cited by 48
Natural Killer Cells: Friend or Foe in Metabolic Diseases?
Li, Y., Wang, F., İmani, S., Tao, L., Deng, Y., & Cai, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.614429 · Cited by 50
“Using the PCR-SSP method, Chinniah R et al. revealed the existence of different KIR genotypes and KIR-HLA receptor combinations between T2DM patients and healthy controls (109).”
BackgroundInfluentialLi, K., Yuan, M., Wu, Y., Pineda, M. A., Zhang, C., Chen, Y., Chen, Z., Rong, X., Turnbull, J. E., & Guo, J. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100950 · Cited by 47
Kimura, I., Kagawa, S., Tsuneki, H., Tanaka, K. Y., & Nagashima, F. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108159 · Cited by 47
Adipokines in glucose and lipid metabolism
Wang, X., Zhang, S., & Li, Z. (2023) · Adipocyte · doi:10.1080/21623945.2023.2202976 · Cited by 51
“lysaccharide (LPS) in the intestinal flora, which initiates the inflammatory cascade by activating pattern recognition TLR4 and leads to insulin resistance [129,130].”
BackgroundAsao, T., Tobias, G. C., Lucotti, S., Jones, D. R., Matei, I. R., & Lyden, D. C. (2023) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2023.37 · Cited by 51
“This disruption can result in dysregulated glucose and insulin levels, potentially causing insulin resistance, increased inflammation, and promoting cancer progression [116–119] .”
BackgroundKia, K., Fitch, S., Newsom, S. A., & Kim, J. H. (2020) · Applied Ergonomics · doi:10.1016/j.apergo.2020.103065 · Cited by 47
Sato, F. T., Yap, Y. A., Crisma, A. R., Portovedo, M., Murata, G. M., Hirabara, S. M., Ribeiro, W. R., Ferreira, C. M., Cruz, M. M., Pereira, J. N. B., et al. (2020) · Cells · doi:10.3390/cells9092007 · Cited by 48
“These contribute to the impairment of multiple organs including the adipose tissue, pancreas, liver and skeletal muscle, which may underlie the link between obesity and the associated diseases [4,5].”
BackgroundThe role of leptin in selected skin diseases
Dopytalska, K., Baranowska-Bik, A., Roszkiewicz, M., Bik, W., & Walecka, I. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01391-8 · Cited by 47
β-elemene regulates M1-M2 macrophage balance through the ERK/JNK/P38 MAPK signaling pathway
Zhou, Y., Takano, T., Li, X., Wang, Y., Wang, R., Zhu, Z., Tanokura, M., Miyakawa, T., & Hachimura, S. (2022) · Communications Biology · doi:10.1038/s42003-022-03369-x · Cited by 46
Yang, W., Chang, Y., Chang, C., Wu, L., Wang, J., & Lin, H.-H. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa545 · Cited by 46
“Obesity is associated with an altered immune response [4] and chronic inflammation [5], which can lead to an increased risk of infection.”
BackgroundMolani‐Gol, R., & Rafraf, M. (2021) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2021.06.011 · Cited by 47
Wang, T., Xu, H. Y., Dong, R., Wu, S., Guo, Y., & Wang, D. (2023) · Food Research International · doi:10.1016/j.foodres.2023.112567 · Cited by 52
D’Espessailles, A., Mora, Y. A., Fuentes, C., & Cifuentes, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26490 · Cited by 46
“Accordingly, upstream inhibition of this pathway with U0126 reverted IL-1β mRNA elevation, which is consistent with other reports (Scherle et al., 1998; Wang, Wu, Huang, & Yang, 2004).”
ResultSindhu, S. T. A. K., Kochumon, S., Thomas, R., Bennakhi, A., Al‐Mulla, F., & Ahmad, R. (2020) · Cells · doi:10.3390/cells9030730 · Cited by 46
“Increasing evidence supports that metabolic inflammation is a consequence of obesity and it may play, in turn, a causative role in blunting insulin sensitivity and disrupting metabolic/energy homeostasis [1,2].”
BackgroundHomeostatic Regulation of Glucose Metabolism by the Central Nervous System
Choi, J. H., & Kim, M.-S. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1364 · Cited by 52
“Similar pathological events may also occur in the brain areas that control glucose metabolism [95].”
BackgroundCatechins and Proanthocyanidins Involvement in Metabolic Syndrome
Patanè, G. T., Putaggio, S., Tellone, E., Barreca, D., Ficarra, S., Maffei, C., Calderaro, A., & Laganà, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119228 · Cited by 45
Natural products targeting inflammation-related metabolic disorders: A comprehensive review
Nainu, F., Frediansyah, A., Mamada, S. S., Permana, A. D., Salampe, M., Chandran, D., Emran, T. B., & Simal‐Gándara, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16919 · Cited by 48
“Nevertheless, chronic inflammation appears to be one of the key players in the initiation, progression, and transition of the abovementioned metabolic disorders [103,129,225,269].”
BackgroundInfluentialMarra, A., Bondesan, A., Caroli, D., & Sartório, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051353 · Cited by 47
“During an inflammatory response, the body activates a series of events involving circulating white blood cells (i.e., neutrophils) [14], which in turn may stimulate the secretion of cytokines and proteolytic enzymes.”
BackgroundMicroglia immunometabolism: From metabolic disorders to single cell metabolism
Paolicelli, R. C., & Angiari, S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.03.012 · Cited by 47
Li, P., Huang, J., Xiao, N., Cai, X., Yang, Y., Deng, J., Zhang, L., & Du, B. (2020) · Food & Function · doi:10.1039/d0fo01178a · Cited by 49
Li, C., Liu, H., Yang, J., Mu, J., Wang, R., & Zhao, X. (2020) · RSC Advances · doi:10.1039/d0ra06977a · Cited by 45
Lourido, F., Quenti, D., Salgado-Canales, D., & Tobar, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-82944-4 · Cited by 48
From Metabolic Syndrome to Neurological Diseases: Role of Autophagy
Maiuolo, J., Gliozzi, M., Musolino, V., Carresi, C., Scarano, F., Nucera, S., Scicchitano, M., Bosco, F., Ruga, S., Zito, M. C., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.651021 · Cited by 49
The intestinal mycobiome as a determinant of host immune and metabolic health
Gutierrez, M. W., & Arrieta, M. (2021) · Current Opinion in Microbiology · doi:10.1016/j.mib.2021.04.004 · Cited by 45
Wang, W., Yang, J., Xu, J., Yu, H., Liu, Y., Wang, R., Ho, R., Ho, C. S. H., & Pan, F. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.11.015 · Cited by 46
Folic Acid Attenuates High-Fat Diet-Induced Osteoporosis Through the AMPK Signaling Pathway
He, H., Zhang, Y., Sun, Y., Zhang, Y., Xu, J., Yang, Y., & Chen, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.791880 · Cited by 44
Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity
Marrano, N., Biondi, G., Borrelli, A., Rella, M., Zambetta, T., Gioia, L. D., Caporusso, M., Logroscino, G., Perrini, S., Giorgino, F., et al. (2023) · Biomolecules · doi:10.3390/biom13010183 · Cited by 44
Obesity, obesities and gastrointestinal cancers
Zou, Y., & Pitchumoni, C. S. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101592 · Cited by 47
Identifying Microbe-Disease Association Based on a Novel Back-Propagation Neural Network Model
Li, H., Wang, Y., Zhang, Z., Tan, Y., Chen, Z., Wang, X., Pei, T., & Wang, L. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.2986459 · Cited by 44
“Obesity is more likely to cause health complications such as insulin resistance, type 2 diabetes, cardiovascular disease, liver disease, cancer, and neurodegeneration [68].”
BackgroundXu, L., Li, D., Zhu, Y., Cai, S., Liang, X., Ying, T., Jin, S., & Ding, C. (2021) · Adipocyte · doi:10.1080/21623945.2021.1906510 · Cited by 43
“tance, has been observed in association with a higher fat mass [3,4].”
BackgroundJiang, L., Li, L., Xu, Z., Tang, Y. R., Zhai, Y., Fu, X., Liu, D., & Wu, Q. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1360874 · Cited by 43
Khalaf, F. K., Dube, P. R., Mohamed, A., Tian, J., Malhotra, D. K., Haller, S. T., & Kennedy, D. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092576 · Cited by 43
“Diabetes mellitus is another inflammation-related process that appears to be increasing rapidly, threatening to reduce life expectancy for humans worldwide [99,105].”
BackgroundAl‐Shaer, A. E., Buddenbaum, N., & Shaikh, S. R. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158936 · Cited by 47
Kaur, H., Kaur, G., Gupta, T., Mittal, D., & Ali, S. A. (2023) · Biology · doi:10.3390/biology12091200 · Cited by 47
“A more comprehensive investigation is warranted to thoroughly grasp the contributions of the lower-gut microbiome to both animal health and productive outcomes [110].”
Region-specific transcriptomic responses to obesity and diabetes in macaque hypothalamus
Lei, Y., Liang, X., Sun, Y., Yao, T. S., Gong, H., Chen, Z., Gao, Y., Wang, H., Wang, R., Huang, Y., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.003 · Cited by 44
Cho, Y., Park, J., Kang, H. J., Kim, W., Cho, M. J., Jang, J.-H., Kwon, M., Kim, S., Lee, S., Lee, J., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.027 · Cited by 42
Vugic, L., Colson, N., Nikbakht, E., Gaiz, A. A., Holland, O. J., Kundur, A., & Singh, I. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103596 · Cited by 47
“…found cytokines such as interleukin (IL)-6, IL-1β and chemokine (C-C motif) ligand 2 (CCL2; also known as monocyte chemoattractant protein-1 (MCP-1)) were elevated in the adipose tissue of obese animals and humans (Bing, 2015; Eder, Baffy, Falus, & Fulop, 2009; Panee, 2012; Reilly & Saltiel, 2017).”
BackgroundWang, L., Pydi, S. P., Zhu, L., Barella, L. F., Cui, Y., Gavrilova, O., Bence, K. K., Vernochet, C., & Wess, J. (2020) · Nature Communications · doi:10.1038/s41467-020-16756-x · Cited by 43
Berries as a Treatment for Obesity-Induced Inflammation: Evidence from Preclinical Models
Lail, H. L., Feresin, R. G., Hicks, D., Stone, B., Price, E., & Wanders, D. (2021) · Nutrients · doi:10.3390/nu13020334 · Cited by 46
“The heightened inflammatory state of these metabolically important tissues has been postulated to increase the risk of developing type 2 diabetes [6,7], cardiovascular disease [8], and cancer [9].”
BackgroundBarrea, L., Muscogiuri, G., Aprano, S., Vetrani, C., de Alteriis, G., Varcamonti, L., Verde, L., Colao, A., & Savastano, S. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01152-w · Cited by 46
“Chronic, low-grade inflammation associated with excess, dysfunctional visceral adipose tissue is an underlying feature of obesity-related diseases [35].”
BackgroundObesity and COVID-19: A Fatal Alliance
Banerjee, M., Gupta, S., Sharma, P., Shekhawat, J. K., & Gauba, K. (2020) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-020-00909-2 · Cited by 41
Proteobacteria impair anti-tumor immunity in the omentum by consuming arginine
Meza‐Perez, S., Liu, M., Silva-Sánchez, A., Morrow, C. D., Eipers, P. G., Lefkowitz, E. J., Ptacek, T., Scharer, C. D., Rosenberg, A. F., Hill, D. D., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.06.003 · Cited by 42
Kitamura, H., Saito, N., Fujimoto, J., Nakashima, K., & Fujikura, D. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2198-5 · Cited by 41
“Background Low-grade inflammation in adipose tissue is a hallmark of type 2 diabetes and adiposity [1].”
Zhou, S.-S., Au-Yeung, K. K. W., Yip, K.-M., Ye, R., Zhao, Z., Mao, Q., Xu, J., Chen, H., & Li, S. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.11.021 · Cited by 42
Apolipoprotein M: a novel adipokine decreasing with obesity and upregulated by calorie restriction
Šrámková, V., Berend, S., Šiklová, M., Caspar‐Bauguil, S., Carayol, J., Bonnel, S., Marqués, M.-A., Decaunes, P., Kolditz, C.-I., Dahlman, I. A., et al. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy331 · Cited by 43
Sugawara, T., Sawada, D., Yanagihara, S., Aoki, Y., Takehara, I., Sugahara, H., Hirota, T., Nakamura, Y., & Ishikawa, S. (2020) · Microorganisms · doi:10.3390/microorganisms8020304 · Cited by 41
“Several studies have shown that the adipose tissue of obese organisms exhibits chronic low-grade inflammation [50,51], and upregulating anti-inflammatory immune activities by increasing the level of butyrate has the potential to affect obesity.”
BackgroundTang, R., Fan, Y., Luo, M., Zhang, D., Xie, Z., Huang, F., Wang, Y., Liu, G., Wang, Y., Lin, S., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.814872 · Cited by 40
“Overweight and obesity are established risk factors for many metabolic diseases (33), which have become an increasingly public health problem.”
BackgroundZhong, W., Wang, X., Yang, L., Wang, Y., Xiao, Q., Yu, S., Cannon, R. D., Bai, Y., Zhang, C., Chen, D., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c08146 · Cited by 40
Association between vitamin D status and metabolic syndrome risk factors
Barbalho, S. M., Tofano, R. J., de Campos, A. L., Rodrigues, A. S., Quesada, K. R., Bechara, M. D., Goulart, R. D. Á., & Oshiiwa, M. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.03.011 · Cited by 40
Metadata
- Authors
- Saltiel, A. R., & Olefsky, J. M.
- Affiliations
- University of California San Diego (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2017-01-03
- Volume
- 127
- Issue
- 1
- Pages
- 1-4
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5199709
- OpenAlex
- W2567264284
- Cited by
- 2,212
- References
- 44
- Citations by year
- 2026: 261 · 2025: 318 · 2024: 265 · 2023: 255 · 2022: 308 · 2021: 280 · 2020: 270 · 2019: 136 · 2018: 80 · 2017: 36
- FWCI
- 18.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- University of California, San Diego (P30DK063491, DK063491)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, P30DK063491)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- obesity, metabolic syndrome, low-grade inflammation, insulin resistance, type 2 diabetes, adipose tissue expansion, innate immune system, adaptive immunity, neuroinflammation, liver inflammation, intestinal inflammation, skeletal muscle inflammation, fibrosis, angiogenesis, anti-inflammatory therapy
- MeSH terms
- Animals, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Inflammation, Neoplasms, Obesity, Organ Specificity, Neurodegenerative Diseases, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review